BIOLOGIC PRODUCTS INSTITUTE TRANSFER - S.B. 846 (S-1): FLOOR ANALYSIS

Senate Bill 846 (Substitute S-1 as reported)

Sponsor: Senator Robert Geake

Committee: Appropriations

CONTENT

The bill would amend the Michigan Biologic Products Institute Transfer Act, effective February 17, 1998, to transfer, by Type I transfer, the Michigan Biologic Products Institute and the Michigan Biologic Products Commission to the Department of Community Health (DCH). The bill would establish the Institute as an autonomous entity within DCH and would give it the authority to carry out its duties, including but not limited to, personnel, budgeting, procurement, and management- related functions independently of the principal executive branch departments. The powers, duties, and responsibilities of the Institute and Commission would be those prescribed in Executive Order 1995-25.

The bill also would make appropriations for the Institute for FY 1997-98. Currently, the FY 1997-98 General Government Appropriation Act includes language that appropriates $9 million for the operation of the Institute. The bill would repeal the language in the General Government Appropriation Act, and instead would appropriate $18 million for the full fiscal year. The $18 million appropriation would be supported through biologic products sales and Federal revenue sources. Also included in the bill is language that would enable the Institute to receive an additional $5 million in Federal, $5 million in State restricted, $100,000 in local, and $500,000 in private revenue sources through the appropriations transfer process should such additional revenue become available.

MCL 333.26333 et al.

FISCAL IMPACT

The bill would appropriate $18,000,000 Gross, $3,000,000 Federal, and $15,000,000 State restricted revenue and authorize 200 FTE positions for the operation of the Michigan Biologic Products Institute in FY 1997-98.

Date Completed: 1-28-98 - Fiscal Analyst: P. Graham

floor\SB846

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.